Dr. Bojana Jovanovic is a Sterling Heights, Michigan based female rheumatologist who is specialized in Rheumatology. Active license number of Dr. Bojana Jovanovic for Rheumatology is 4301111372 in Michigan. Dr. Bojana Jovanovic treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Bojana Jovanovic speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Female
Practice Address:
14500 Hall Rd, Sterling Heights, Michigan, 48313-1229
Phone:
313-916-2631
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1962781807
NPI Enumeration Date:
09 Aug, 2011
NPI Last Update On:
17 Mar, 2018
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Bojana Jovanovic are as mentioned below.
License Number
Specialization
State
Status
4301111372
Rheumatologist
Michigan
Primary
284175
Rheumatology
New York
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
14500 Hall Rd, Sterling Heights, Michigan
Zip:
48313-1229
Phone Number:
313-916-2631
Fax Number:
--
Patients can reach Dr. Bojana Jovanovic at 14500 Hall Rd, Sterling Heights, Michigan or can call to book an appointment on 313-916-2631. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.